.It is notable that for AMPs, selection for resistant
mutants could occur at two levels: (i) due to therapeutic use
of AMPs (which might generate very strong selective pressures),
and (ii) due to continuous selection provided by AMPs produced in
the human body and to which bacterial pathogens can be exposed.